Global Losartan Potassium Tablets Market Size, Share, and COVID-19 Impact Analysis, By Strength (25 mg, 50 mg, and 100 mg), By Indication (Hypertension, Heart Failure, Chronic Kidney Disease, and Others), By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2025 - 2035

Industry: Healthcare

RELEASE DATE Oct 2025
REPORT ID SI15928
PAGES 240
REPORT FORMAT PathSoft

  1. Introduction
    1. Objectives of the Study
    2. Market Definition
    3. Research Scope
  2. Research Methodology and Assumptions
  3. Executive Summary
  4. Premium Insights
    1. Porter’s Five Forces Analysis
    2. Value Chain Analysis
    3. Top Investment Pockets
      1. Market Attractiveness Analysis, By Strength
      2. Market Attractiveness Analysis, By Indication
      3. Market Attractiveness Analysis, By Region
    4. Industry Trends
  5. Market Dynamics
    1. Market Evaluation
    2. Drivers
      1. Increased prevalence of hypertension and increasing geriatric population
    3. Restraints
      1.  Strict regulations and limited patient adherence
    4. Opportunities
      1.  Rising disposable incomes and expanding healthcare infrastructure
    5. Challenges
      1. Increased regulatory scrutiny
  6. Global Losartan Potassium Tablets Market Analysis and Projection, By Strength
    1. Segment Overview
    2. 25 mg
    3. 50 mg
    4. 100 mg
  7. Global Losartan Potassium Tablets Market Analysis and Projection, By Indication
    1. Segment Overview
    2. Hypertension
    3. Heart Failure
    4. Chronic Kidney Disease
    5. Others
  8. Global Losartan Potassium Tablets Market Analysis and Projection, By Regional Analysis
    1. Segment Overview
    2. North America
      1. U.S.
      2. Canada
      3. Mexico
    3. Europe
      1. Germany
      2. France
      3. U.K.
      4. Italy
      5. Spain
    4. Asia-Pacific
      1. Japan
      2. China
      3. India
    5. South America
      1. Brazil
    6. Middle East and Africa
      1. UAE
      2. South Africa
  9. Global Losartan Potassium Tablets Market-Competitive Landscape
    1. Overview
    2. Market Share of Key Players in the Losartan Potassium Tablets Market
      1. Global Company Market Share
      2. North America Company Market Share
      3. Europe Company Market Share
      4. APAC Company Market Share
    3. Competitive Situations and Trends
      1. Coverage Launches and Developments
      2. Partnerships, Collaborations, and Agreements
      3. Mergers & Acquisitions
      4. Expansions
  10. Company Profiles
    1. Merck & Co.
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    2.   Teva Pharmaceutical Industries Ltd. 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    3.  Pfizer Inc. 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    4.   Zydus Lifesciences Ltd. 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    5.   Sanofi S.A. 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    6.  Mylan N.V.
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    7.   Dr. Reddy’s Laboratories
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    8. Lupin Limited
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    9.  Novartis International AG
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    10.  Aurobindo Pharma Limited 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    11.  Torrent Pharmaceuticals
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    12.   Sun Pharmaceutical Industries Limited
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    13.  Others 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis

 

List of Tables

  1. Global Losartan Potassium Tablets Market, By Strength, 2024-2035(USD Billion)
  2. Global 25 mg, Losartan Potassium Tablets Market, By Region, 2024-2035(USD Billion)
  3. Global 50 mg, Losartan Potassium Tablets Market, By Region, 2024-2035(USD Billion)
  4. Global 100 mg, Losartan Potassium Tablets Market, By Region, 2024-2035(USD Billion)
  5. Global Losartan Potassium Tablets Market, By Indication, 2024-2035(USD Billion)
  6. Global Hypertension, Losartan Potassium Tablets Market, By Region, 2024-2035(USD Billion)
  7. Global Heart Failure, Losartan Potassium Tablets Market, By Region, 2024-2035(USD Billion)
  8. Global Chronic Kidney Disease, Losartan Potassium Tablets Market, By Region, 2024-2035(USD Billion)
  9. Global Others, Losartan Potassium Tablets Market, By Region, 2024-2035(USD Billion)
  10. North America Losartan Potassium Tablets Market, By Strength, 2024-2035(USD Billion)
  11. North America Losartan Potassium Tablets Market, By Indication, 2024-2035(USD Billion)
  12. U.S.  Losartan Potassium Tablets Market, By Strength, 2024-2035(USD Billion)
  13. U.S.  Losartan Potassium Tablets Market, By Indication, 2024-2035(USD Billion)
  14. Canada Losartan Potassium Tablets Market, By Strength, 2024-2035(USD Billion)
  15. Canada Losartan Potassium Tablets Market, By Indication, 2024-2035(USD Billion)
  16. Mexico Losartan Potassium Tablets Market, By Strength, 2024-2035(USD Billion)
  17. Mexico Losartan Potassium Tablets Market, By Indication, 2024-2035(USD Billion)
  18. Europe Losartan Potassium Tablets Market, By Strength, 2024-2035(USD Billion)
  19. Europe Losartan Potassium Tablets Market, By Indication, 2024-2035(USD Billion)
  20. Germany Losartan Potassium Tablets Market, By Strength, 2024-2035(USD Billion)
  21. Germany Losartan Potassium Tablets Market, By Indication, 2024-2035(USD Billion)
  22. France Losartan Potassium Tablets Market, By Strength, 2024-2035(USD Billion)
  23. France Losartan Potassium Tablets Market, By Indication, 2024-2035(USD Billion)
  24. U.K.  Losartan Potassium Tablets Market, By Strength, 2024-2035(USD Billion)
  25. U.K.  Losartan Potassium Tablets Market, By Indication, 2024-2035(USD Billion)
  26. Italy Losartan Potassium Tablets Market, By Strength, 2024-2035(USD Billion)
  27. Italy Losartan Potassium Tablets Market, By Indication, 2024-2035(USD Billion)
  28. Spain Losartan Potassium Tablets Market, By Strength, 2024-2035(USD Billion)
  29. Spain Losartan Potassium Tablets Market, By Indication, 2024-2035(USD Billion)
  30. Asia Pacific Losartan Potassium Tablets Market, By Strength, 2024-2035(USD Billion)
  31. Asia Pacific Losartan Potassium Tablets Market, By Indication, 2024-2035(USD Billion)
  32. Japan Losartan Potassium Tablets Market, By Strength, 2024-2035(USD Billion)
  33. Japan Losartan Potassium Tablets Market, By Indication, 2024-2035(USD Billion)
  34. China Losartan Potassium Tablets Market, By Strength, 2024-2035(USD Billion)
  35. China Losartan Potassium Tablets Market, By Indication, 2024-2035(USD Billion)
  36. India Losartan Potassium Tablets Market, By Strength, 2024-2035(USD Billion)
  37. India Losartan Potassium Tablets Market, By Indication, 2024-2035(USD Billion)
  38. South America Losartan Potassium Tablets Market, By Strength, 2024-2035(USD Billion)
  39. South America Losartan Potassium Tablets Market, By Indication, 2024-2035(USD Billion)
  40. Brazil Losartan Potassium Tablets Market, By Strength, 2024-2035(USD Billion)
  41. Brazil Losartan Potassium Tablets Market, By Indication, 2024-2035(USD Billion)
  42. The Middle East and Africa Losartan Potassium Tablets Market, By Strength, 2024-2035(USD   Billion)
  43. The Middle East and Africa Losartan Potassium Tablets Market, By Indication, 2024-2035(USD   Billion)
  44. UAE Losartan Potassium Tablets Market, By Strength, 2024-2035(USD Billion)
  45. UAE Losartan Potassium Tablets Market, By Indication, 2024-2035(USD Billion)
  46. South Africa Losartan Potassium Tablets Market, By Strength, 2024-2035(USD Billion)
  47. South Africa Losartan Potassium Tablets Market, By Indication, 2024-2035(USD Billion)

 

List of Figures 

  1. Global Losartan Potassium Tablets Market Segmentation
  2. Losartan Potassium Tablets Market: Research Methodology
  3. Market Size Estimation Methodology: Bottom-Up Approach
  4. Market Size Estimation Methodology: Top-down Approach
  5. Data Triangulation
  6. Porter’s Five Forces Analysis
  7. Value Chain Analysis
  8. Top investment pocket in the Losartan Potassium Tablets Market
  9. Top Winning Strategies, 2024-2035
  10. Top Winning Strategies, By Development, 2024-2035(%)
  11. Top Winning Strategies, By Company, 2024-2035
  12. Moderate Bargaining Power of Buyers
  13. Moderate Bargaining Power of Suppliers
  14. Moderate Bargaining Power of New Entrants
  15. Low threat of Substitution
  16. High Competitive Rivalry
  17. Top Player Positioning, 2024
  18. Market Share Analysis, 2024
  19. Restraint and Drivers:  Losartan Potassium Tablets Market
  20. Losartan Potassium Tablets Market Segmentation, By Strength
  21. Losartan Potassium Tablets Market For 25 mg, By Region, 2024-2035 ($ Billion)
  22.  Losartan Potassium Tablets Market For 50 mg, By Region, 2024-2035 ($ Billion)
  23. Losartan Potassium Tablets Market For 100 mg, By Region, 2024-2035 ($ Billion)
  24.  Losartan Potassium Tablets Market Segmentation, By Indication
  25.  Losartan Potassium Tablets Market For Hypertension, By Region, 2024-2035 ($ Billion)
  26.  Losartan Potassium Tablets Market For Heart Failure, By Region, 2024-2035 ($ Billion)
  27. Losartan Potassium Tablets Market For Chronic Kidney Disease, By Region, 2024-2035 ($ Billion)
  28. Losartan Potassium Tablets Market For Others, By Region, 2024-2035 ($ Billion)
  29. Merck & Co.: Net Sales, 2024-2035 ($ Billion)
  30. Merck & Co.: Revenue Share, By Segment, 2024 (%)
  31. Merck & Co.: Revenue Share, By Region, 2024 (%)
  32. Teva Pharmaceutical Industries Ltd.: Net Sales, 2024-2035 ($ Billion)
  33. Teva Pharmaceutical Industries Ltd.: Revenue Share, By Segment, 2024 (%)
  34. Teva Pharmaceutical Industries Ltd.: Revenue Share, By Region, 2024 (%)
  35. Pfizer Inc.: Net Sales, 2024-2035 ($ Billion)
  36. Pfizer Inc.: Revenue Share, By Segment, 2024 (%)
  37. Pfizer Inc.: Revenue Share, By Region, 2024 (%)
  38. Zydus Lifesciences Ltd.: Net Sales, 2024-2035 ($ Billion)
  39. Zydus Lifesciences Ltd.: Revenue Share, By Segment, 2024 (%)
  40. Zydus Lifesciences Ltd.: Revenue Share, By Region, 2024 (%)
  41. Sanofi S.A.: Net Sales, 2024-2035 ($ Billion)
  42. Sanofi S.A.: Revenue Share, By Segment, 2024 (%)
  43. Sanofi S.A.: Revenue Share, By Region, 2024 (%)
  44. Mylan N.V.: Net Sales, 2024-2035 ($ Billion)
  45. Mylan N.V.: Revenue Share, By Segment, 2024 (%)
  46. Mylan N.V.: Revenue Share, By Region, 2024 (%)
  47. Dr. Reddy’s Laboratories: Net Sales, 2024-2035 ($ Billion)
  48. Dr. Reddy’s Laboratories: Revenue Share, By Segment, 2024 (%)
  49. Dr. Reddy’s Laboratories: Revenue Share, By Region, 2024 (%)
  50. Lupin Limited: Net Sales, 2024-2035 ($ Billion)
  51. Lupin Limited: Revenue Share, By Segment, 2024 (%)
  52. Lupin Limited: Revenue Share, By Region, 2024 (%)
  53. Novartis International AG.: Net Sales, 2024-2035 ($ Billion)
  54. Novartis International AG.: Revenue Share, By Segment, 2024 (%)
  55. Novartis International AG.: Revenue Share, By Region, 2024 (%)
  56. Aurobindo Pharma Limited: Net Sales, 2024-2035 ($ Billion)
  57. Aurobindo Pharma Limited: Revenue Share, By Segment, 2024 (%)
  58. Aurobindo Pharma Limited: Revenue Share, By Region, 2024 (%)
  59. Torrent Pharmaceuticals: Net Sales, 2024-2035 ($ Billion)
  60. Torrent Pharmaceuticals: Revenue Share, By Segment, 2024 (%)
  61. Torrent Pharmaceuticals: Revenue Share, By Region, 2024 (%)
  62. Sun Pharmaceutical Industries Limited: Net Sales, 2024-2035 ($ Billion)
  63. Sun Pharmaceutical Industries Limited: Revenue Share, By Segment, 2024 (%)
  64. Sun Pharmaceutical Industries Limited: Revenue Share, By Region, 2024 (%)
  65. Others: Net Sales, 2024-2035 ($ Billion)
  66. Others: Revenue Share, By Segment, 2024 (%)
  67. Others: Revenue Share, By Region, 2024 (%)

Need help to buy this report?

Inquiry Before Buy
We'll use cookies to improve and customize your experience if you continue to browse. Is it OK if we also use cookies to show you personalized ads?
Learn more and manage your cookies
Yes, Accept Cookies